Sarepta Therapeutics
SRPT
#1525
Rank
HK$90.30 B
Marketcap
HK$945.46
Share price
0.99%
Change (1 day)
49.94%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): HK$0.48 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are HK$1.50 Billion. In 2023 the company made an earning of -HK$4.05 Billion, an increase over its 2022 earnings that were of -HK$5.37 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) HK$0.48 B-112.02%
2023 -HK$4.05 Billion-24.62%
2022 -HK$5.37 Billion64.69%
2021 -HK$3.26 Billion-24.25%
2020 -HK$4.3 Billion-22.53%
2019 -HK$5.56 Billion96.87%
2018 -HK$2.82 Billion645.68%
2017 -HK$0.38 Billion-81.81%
2016 -HK$2.08 Billion21.47%
2015 -HK$1.72 Billion62.04%
2014 -HK$1.06 Billion21.26%
2013 -HK$0.88 Billion60.93%
2012 -HK$0.55 Billion93.69%
2011 -HK$0.28 Billion71.58%
2010 -HK$0.17 Billion35.06%
2009 -HK$0.13 Billion-11.62%
2008 -HK$0.14 Billion-47.02%
2007 -HK$0.26 Billion0.38%
2006 -HK$0.26 Billion88.3%
2005 -HK$0.14 Billion-30.06%
2004 -HK$0.2 Billion32.69%
2003 -HK$0.15 Billion-25.52%
2002 -HK$0.2 Billion64.52%
2001 -HK$0.12 Billion50.4%
2000 -HK$79.63 Million26.44%
1999 -HK$62.98 Million8%
1998 -HK$58.31 Million102.7%
1997 -HK$28.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
HK$11.95 B 2,371.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.13 Billion-539.79%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.97 Billion-505.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.14 Billion-335.44%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$1.46 Billion-400.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$3.85 Billion-894.04%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$6.07 Billion-1,354.49%๐Ÿ‡บ๐Ÿ‡ธ USA